Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 3546 entries
View as:

Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B

Phase: N/A Priority: Normal
NCT ID: NCT02901951 Org: User:
Start: 10/11/16 End: 05/01/17 Due: 05/01/18

A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00896558 Org: User:
Start: 05/11/09 End: 09/25/09 Due: 09/25/10

Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

Phase: N/A Priority: Normal
NCT ID: NCT00133874 Org: User:
Start: 04/30/05 End: 09/30/05 Due: 09/30/06

Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT03848845 Org: User:
Start: 03/14/19 End: 06/14/23 Due: 06/14/24

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Phase: N/A Priority: Normal
NCT ID: NCT00228917 Org: User:
Start: 06/16/05 End: 01/20/06 Due: 01/20/07

HEPSERA Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01329419 Org: User:
Start: 08/31/04 End: 02/28/10 Due: 02/28/11

Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.

Phase: N/A Priority: Normal
NCT ID: NCT00380393 Org: User:
Start: 01/03/07 End: 11/11/08 Due: 11/11/09

A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT02925546 Org: User:
Start: 10/31/16 End: 12/31/16 Due: 12/31/17

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00603746 Org: User:
Start: 12/01/07 End: 09/20/08 Due: 09/20/09

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00320463 Org: User:
Start: 04/30/06 End: 01/31/07 Due: 01/31/08

A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses

Phase: N/A Priority: Normal
NCT ID: NCT03266172 Org: User:
Start: 09/27/17 End: 11/21/18 Due: 11/21/19

A First-Time-In-Human Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00857883 Org: User:
Start: 11/17/08 End: 08/01/09 Due: 08/01/10

The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury

Phase: N/A Priority: Normal
NCT ID: NCT01597635 Org: User:
Start: 09/01/12 End: 10/06/14 Due: 10/06/15

Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00968890 Org: User:
Start: 09/12/09 End: 09/23/10 Due: 09/23/11

Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants

Phase: N/A Priority: Normal
NCT ID: NCT04311463 Org: User:
Start: 12/09/20 End: 01/02/21 Due: 01/02/22

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

Phase: N/A Priority: Normal
NCT ID: NCT00383162 Org: User:
Start: 11/30/06 End: 10/31/07 Due: 10/31/08

Single and Repeated Dose Escalation Study of GSK2838232

Phase: N/A Priority: Normal
NCT ID: NCT02795754 Org: User:
Start: 03/31/16 End: 12/31/16 Due: 12/31/17

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00348309 Org: User:
Start: 07/06/06 End: 01/28/09 Due: 01/28/10

Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study

Phase: N/A Priority: Normal
NCT ID: NCT01424527 Org: User:
Start: 12/31/10 End: 04/30/11 Due: 04/30/12

Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00376896 Org: User:
Start: 11/30/06 End: 10/31/08 Due: 10/31/09

HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01147848 Org: User:
Start: 06/30/10 End: 07/31/11 Due: 07/31/12

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01772199 Org: User:
Start: 02/28/13 End: 09/30/14 Due: 09/30/15

A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01039909 Org: User:
Start: 01/31/11 End: 02/28/11 Due: 02/28/12

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Phase: N/A Priority: Normal
NCT ID: NCT01313663 Org: User:
Start: 02/28/11 End: 07/31/12 Due: 07/31/13

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT02699099 Org: User:
Start: 05/10/17 End: 10/07/20 Due: 10/07/21